Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version.

Jiwon Yun,Jung-Ah Kim,J.-O. Park,Kyongok Im,Young Eun Lee,Dajeong Jeong,Sohee Ryu,Kyu Min Lim,Sung Min Kim,Yong Oon Ahn,Dong Soon Lee

Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version.

2020

Jiwon Yun
Jung-Ah Kim
J.-O. Park
Kyongok Im
Young Eun Lee
Dajeong Jeong
Sohee Ryu
Kyu Min Lim
Sung Min Kim
Yong Oon Ahn
Dong Soon Lee

The 2016 revised World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues was published in September 2017 [1]. Compared to the 2008 WHO guidelines, there were ...

Keywords:

Philadelphia Chromosome Negative
Medicine
Myeloproliferative neoplasm
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations